3D Technology-Driven 2D Mask Selector for Personalized Care

3D Technology-Driven 2D Mask Selector for Personalized Care

By Healthcare Tech Outlook | Tuesday, July 14, 2020

The premier solution helps health care deliverers to select and provide the right and tailored masks for patients.

FREMONT, CA: One of the leading health technology companies, Royal Philips, has launched the Philips Respironics Mask Selector. It is the world's first mask selection, validation, and assessment solution that is backed by 3D facial scanning technology. This new Respironics Mask Selector allows the care providers to perform masksizing, resizing, fitting, and verification functions easier and faster than ever. The only clinically validated Respironics, helps providers realize increased heights of operational efficiencies as it lets them fit almost 9 out of 10 patients with the right mask, thereby attaining 90% accuracy and hit ratio.

The proprietary Mask Selector algorithm developed by Philips serves as an innovative solution in the march towards digitalizing multiple or all the aspects of health care. The solution also improves business outcomes and cuts costs. The mask selector holds the mission to transform the legacy and traditional ways DMEs and sleep labs work in delivering care. Respironics Mask Selector works with the help of data processing algorithms, thereby helps in precisely deciding between the masks that aptly suit the patients and those that don’t. This solution features personalized service delivery as it takes into account the characteristics of each of the patients and delivers outcomes unique to the patients.

3D scanning technology coupled with this 2D mask selector tool induces accuracy in sizing and fitting experience and enhances Philips's commitment to delivering promising and reliable support to patients to overcome the situation especially pertaining to that of COVID. The health technology company, Royal Philips leverages technology to deliver excellent health outcomes to its users and patients. This company is based in the Netherlands and is known for its deeply mastered clinical insights and solutions.

Weekly Brief